FAP
Prolyl endopeptidase FAP
Also known as: DPPIV, SEPR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q12884
- Gene
- FAP
- Ensembl
- ENSG00000078098
- Chromosome
- 2
- Canonical length
- 760 aa
- Protein class
- Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a homodimeric integral membrane gelatinase belonging to the serine protease family. It is selectively expressed in reactive stromal fibroblasts of epithelial cancers, granulation tissue of healing wounds, and malignant cells of bone and soft tissue sarcomas. This protein is thought to be involved in the control of fibroblast growth or epithelial-mesenchymal interactions during development, tissue repair, and epithelial carcinogenesis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2014]
Canonical amino-acid sequenceUniProt
760 residues, UniProt reviewed canonical sequence.
>Q12884|FAP
1 MKTWVKIVFG VATSAVLALL VMCIVLRPSR VHNSEENTMR ALTLKDILNG TFSYKTFFPN
61 WISGQEYLHQ SADNNIVLYN IETGQSYTIL SNRTMKSVNA SNYGLSPDRQ FVYLESDYSK
121 LWRYSYTATY YIYDLSNGEF VRGNELPRPI QYLCWSPVGS KLAYVYQNNI YLKQRPGDPP
181 FQITFNGREN KIFNGIPDWV YEEEMLATKY ALWWSPNGKF LAYAEFNDTD IPVIAYSYYG
241 DEQYPRTINI PYPKAGAKNP VVRIFIIDTT YPAYVGPQEV PVPAMIASSD YYFSWLTWVT
301 DERVCLQWLK RVQNVSVLSI CDFREDWQTW DCPKTQEHIE ESRTGWAGGF FVSTPVFSYD
361 AISYYKIFSD KDGYKHIHYI KDTVENAIQI TSGKWEAINI FRVTQDSLFY SSNEFEEYPG
421 RRNIYRISIG SYPPSKKCVT CHLRKERCQY YTASFSDYAK YYALVCYGPG IPISTLHDGR
481 TDQEIKILEE NKELENALKN IQLPKEEIKK LEVDEITLWY KMILPPQFDR SKKYPLLIQV
541 YGGPCSQSVR SVFAVNWISY LASKEGMVIA LVDGRGTAFQ GDKLLYAVYR KLGVYEVEDQ
601 ITAVRKFIEM GFIDEKRIAI WGWSYGGYVS SLALASGTGL FKCGIAVAPV SSWEYYASVY
661 TERFMGLPTK DDNLEHYKNS TVMARAEYFR NVDYLLIHGT ADDNVHFQNS AQIAKALVNA
721 QVDFQAMWYS DQNHGLSGLS TNHLYTHMTH FLKQCFSLSDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FAP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- endometrium: 29 nTPM
- smooth muscle: 25 nTPM
- placenta: 22 nTPM
- gallbladder: 21 nTPM
- blood vessel: 16 nTPM
- urinary bladder: 15 nTPM
Single-cell type
- fibro-adipogenic progenitors: 234 nCPM
- pancreatic islet cells: 213 nCPM
- müller glia: 203 nCPM
- endometrial stromal cells: 155 nCPM
- decidual stromal cells: 126 nCPM
- fibroblasts: 71 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 3.3 nTPM
- thalamus: 2.7 nTPM
- amygdala: 2.5 nTPM
- basal ganglia: 2.3 nTPM
- white matter: 2 nTPM
- medulla oblongata: 1.8 nTPM
ReferencesPubMed · IEDB
Publications for FAP from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Anti-tumour effects of a xenogeneic fibroblast activation protein-based whole cell tumour vaccine in murine tumour models.
2019 · Artif Cells Nanomed Biotechnol · RCR 0.7 · 18 citations - Tracking tumor alteration in glioma through serum fibroblast activation protein combined with image.
2023 · BMC Cancer · RCR 0.5 · 3 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.1
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.45
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- cell adhesion
- endothelial cell migration
- melanocyte apoptotic process
- melanocyte proliferation
- negative regulation of cell proliferation involved in contact inhibition
- negative regulation of extracellular matrix disassembly
- positive regulation of execution phase of apoptosis
- proteolysis
- proteolysis involved in protein catabolic process
- regulation of cell cycle
- regulation of collagen catabolic process
- regulation of fibrinolysis
- negative regulation of extracellular matrix organization
Molecular functions
- dipeptidyl-peptidase activity
- endopeptidase activity
- identical protein binding
- integrin binding
- peptidase activity
- protease binding
- protein homodimerization activity
- serine-type endopeptidase activity
- serine-type peptidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FAP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FAP as an antibody target. Whether an autoantibody or antibody against FAP could matter depends on whether native FAP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FAP is annotated at the cell surface, where native FAP is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label FAP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...